{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:52:03Z","timestamp":1789213923834,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["24707"],"award-info":[{"award-number":["24707"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shriners of North America","award":["84060-CAN-13"],"award-info":[{"award-number":["84060-CAN-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00223-016-0110-1","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T02:05:45Z","timestamp":1453860345000},"page":"566-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Osteogenesis Imperfecta Type VI in Individuals from Northern Canada"],"prefix":"10.1007","volume":"98","author":[{"given":"Leanne","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghalib","family":"Bardai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Moffatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil","family":"Al-Jallad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Trejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis H","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"110_CR1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","volume":"17","author":"FH Glorieux","year":"2002","unstructured":"Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30\u201338","journal-title":"J Bone Miner Res"},{"key":"110_CR2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bone.2006.10.010","volume":"40","author":"C Land","year":"2007","unstructured":"Land C, Rauch F, Travers R, Glorieux FH (2007) Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone 40:638\u2013644","journal-title":"Bone"},{"key":"110_CR3","first-page":"183","volume":"12","author":"O Semler","year":"2012","unstructured":"Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E (2012) First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact 12:183\u2013188","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"110_CR4","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jbmr.487","volume":"26","author":"EP Homan","year":"2011","unstructured":"Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798\u20132803","journal-title":"J Bone Miner Res"},{"key":"110_CR5","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1210\/jc.2012-1827","volume":"97","author":"F Rauch","year":"2012","unstructured":"Rauch F, Husseini A, Roughley P, Glorieux FH, Moffatt P (2012) Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab 97:E1550\u2013E1556","journal-title":"J Clin Endocrinol Metab"},{"key":"110_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2015.04.008","volume":"76","author":"H Al-Jallad","year":"2015","unstructured":"Al-Jallad H, Palomo T, Roughley P, Glorieux FH, McKee MD, Moffatt P, Rauch F (2015) The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI. Bone 76:115\u2013120","journal-title":"Bone"},{"key":"110_CR7","doi-asserted-by":"crossref","first-page":"E2446","DOI":"10.1210\/jc.2014-2505","volume":"99","author":"H Al-Jallad","year":"2014","unstructured":"Al-Jallad H, Palomo T, Moffatt P, Roughley P, Glorieux FH, Rauch F (2014) Normal bone density and fat mass in heterozygous SERPINF1 mutation carriers. J Clin Endocrinol Metab 99:E2446\u2013E2450","journal-title":"J Clin Endocrinol Metab"},{"key":"110_CR8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jbmr.1730","volume":"28","author":"HJ Kalkwarf","year":"2013","unstructured":"Kalkwarf HJ, Zemel BS, Yolton K, Heubi JE (2013) Bone mineral content and density of the lumbar spine of infants and toddlers: influence of age, sex, race, growth, and human milk feeding. J Bone Miner Res 28:206\u2013212","journal-title":"J Bone Miner Res"},{"key":"110_CR9","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96:3160\u20133169","journal-title":"J Clin Endocrinol Metab"},{"key":"110_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","volume":"26","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM (2000) Normative data for iliac bone histomorphometry in growing children. Bone 26:103\u2013109","journal-title":"Bone"},{"key":"110_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00223-014-9897-9","volume":"95","author":"F Rauch","year":"2014","unstructured":"Rauch F, Lalic L, Glorieux FH, Moffatt P, Roughley P (2014) Targeted sequencing of a pediatric metabolic bone gene panel using a desktop semiconductor next-generation sequencer. Calcif Tissue Int 95:323\u2013331","journal-title":"Calcif Tissue Int"},{"key":"110_CR12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/humu.22812","volume":"36","author":"J Schleit","year":"2015","unstructured":"Schleit J, Bailey SS, Tran T, Chen D, Stowers S, Schwarze U, Byers PH (2015) Molecular outcome, prediction, and clinical consequences of splice variants in COL1A1, which encodes the proalpha1(I) chains of type I procollagen. Hum Mutat 36:728\u2013739","journal-title":"Hum Mutat"},{"key":"110_CR13","doi-asserted-by":"crossref","first-page":"45400","DOI":"10.1074\/jbc.M208339200","volume":"277","author":"C Meyer","year":"2002","unstructured":"Meyer C, Notari L, Becerra SP (2002) Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem 277:45400\u201345407","journal-title":"J Biol Chem"},{"key":"110_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bone.2014.12.023","volume":"73","author":"N Fratzl-Zelman","year":"2015","unstructured":"Fratzl-Zelman N, Schmidt I, Roschger P, Roschger A, Glorieux FH, Klaushofer K, Wagermaier W, Rauch F, Fratzl P (2015) Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone. Bone 73:233\u2013241","journal-title":"Bone"},{"key":"110_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00223-008-9113-x","volume":"82","author":"P Roschger","year":"2008","unstructured":"Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH, Klaushofer K, Rauch F (2008) Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif Tissue Int 82:263\u2013270","journal-title":"Calcif Tissue Int"},{"key":"110_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13023-014-0145-1","volume":"9","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn H, Netzer C, Koerber F, Schoenau E, Semler O (2014) Two years\u2019 experience with denosumab for children with osteogenesis imperfecta type VI. Orphanet J Rare Dis 9:145","journal-title":"Orphanet J Rare Dis"},{"key":"110_CR17","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jbmr.2236","volume":"29","author":"JP Brown","year":"2014","unstructured":"Brown JP, Reid IR, Wagman RB, Kendler D, Miller PD, Jensen JE, Bolognese MA, Daizadeh N, Valter I, Zerbini CA, Dempster DW (2014) Effects of up to 5\u00a0years of denosumab treatment on bone histology and histomorphometry: the FREEDOM study extension. J Bone Miner Res 29:2051\u20132056","journal-title":"J Bone Miner Res"},{"key":"110_CR18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","volume":"96","author":"HG Bone","year":"2011","unstructured":"Bone HG, Bolognese MA, Yuen CK, Kendler DL, Miller PD, Yang YC, Grazette L, San Martin J, Gallagher JC (2011) Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab 96:972\u2013980","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0110-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0110-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:41:15Z","timestamp":1558683675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0110-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}